Vimarsana
Biggest News Aggregation in the World

Page 21 - Focus Fund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Focus Fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Focus Fund Today - Breaking & Trending Today

KAHR Receives Investment from Cancer Focus Fund to Support Phase 1/2 Study of KAHR's Lead Anti-CD47 Candidate in Blood Cancers - Vimarsana News

KAHR Receives Investment from Cancer Focus Fund to Support Phase 1/2 Study of KAHR's Lead Anti-CD47 Candidate in Blood Cancers

/PRNewswire/ -- KAHR, a clinical-stage cancer immunotherapy company developing novel bi-functional fusion proteins, and Cancer Focus Fund, LP, a unique venture...

Mereo BioPharma and Cancer Focus Fund Announce Partnership - Vimarsana News

Mereo BioPharma and Cancer Focus Fund Announce Partnership

Mereo BioPharma and Cancer Focus Fund Announce Partnership for Phase 1b/2 Study of Etigilimab in Clear Cell Ovarian Cancer Study to be Conducted at The University of Texas MD Anderson Cancer Center Mereo BioPharma Group plc; Cancer Focus Fund LONDON, UNITED KINGDOM LONDON and REDWOOD CITY, Calif. and HOUSTON, Texas, April 30, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on oncology and rare diseases, and Cancer Focus Fund, LP, a unique venture capital fund esta...

Mereo BioPharma and Cancer Focus Fund Announce Partnership for Phase 1b/2 Study of Etigilimab in Clear Cell Ovarian CancerStudy to be Conducted at The University of Texas MD Anderson Cancer Center - Vimarsana News

Mereo BioPharma and Cancer Focus Fund Announce Partnership for Phase 1b/2 Study of Etigilimab in Clear Cell Ovarian CancerStudy to be Conducted at The University of Texas MD Anderson Cancer Center

Published: Apr 30, 2021 LONDON and REDWOOD CITY, Calif. and HOUSTON, Texas, April 30, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on oncology and rare diseases, and Cancer Focus Fund, LP, a unique venture capital fund established in collaboration with The University of Texas MD Anderson Cancer Center (“MD Anderson”) to provide funding and clinical expertise to advance promising cancer therapies, today announced a partnership to evaluate Mereo’s lead anti-TIGIT therapeutic ant...

Minnesota Fund Raises $16.6M to Foster Midwest Entrepreneurs - Vimarsana News

Minnesota Fund Raises $16.6M to Foster Midwest Entrepreneurs

Share this article MINNEAPOLIS, April 15, 2021 /PRNewswire/ -- Traction Capital has closed Focus Fund I at a final fund size of $16,605,000. Traction Capital is a Minnesota based hybrid private equity and venture capital firm with a mission of helping entrepreneurs in the Midwest get what they want for the greater good. The fund closed on March 5 th, 2021 with 76 total investors including over 50 Minnesotan Entrepreneurs. Shane Erickson, the Founder and Managing Partner of Traction Capital, first had the vision for the fund while acting as an Angel Investor and mentor of several Minnesota-ba...

Traction Capital Closes on First Investment in Kwikly - Vimarsana News

Traction Capital Closes on First Investment in Kwikly

Traction Capital Closes on First Investment in Kwikly News provided by Share this article MINNEAPOLIS, Feb. 9, 2021 /PRNewswire/ -- Traction Capital is excited to announce its first investment of Focus Fund I in Kwikly. The fund has invested $250,000 in the Minneapolis based company whose platform provides on-demand staffing for dental professionals. Kwikly was founded in 2017 by Pedram Nastaean and Yomiyu Hirpa. The company offers a mobile platform that connects dental hygienists seeking temporary employment with dental offices facing staffing shortages. Kwikly has achieved impressive grow...